The AR N/C interaction in SBMA - Mechanistic role and therapeutic potential
The AR N/C interaction in SBMA - Mechanistic role and therapeutic potential
批准号:
10112974
负责人:
DIANE E MERRY
金额:
$46.62万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-15 至 2023-02-28
关键词:
AF2AblationAdultAgonistAlzheimer&aposs DiseaseAmyotrophic Lateral SclerosisAndrogen ReceptorAndrogensAnimal ModelBindingCell NucleusCell modelCellsCharacteristicsClinical TrialsDNA BindingDevelopmentDimerizationDiseaseDisease ProgressionDisease modelEvaluationEventFailureFamilyGeneticGenetic TranscriptionGoalsHormonalHormonesHuntington DiseaseIn VitroInheritedLeadLigand Binding DomainLigandsLinkLysineMediatingMetabolismModelingMolecularMolecular ConformationMotor NeuronsMusMuscle functionMutationNatureNeurodegenerative DisordersNeuromuscular DiseasesNeuronal DysfunctionNuclearObservational StudyParkinson DiseasePathogenesisPathogenicityPathway interactionsPatientsPhosphorylationPhosphotransferasesPlayProcessPropertyProteinsProteomicsReceptor AggregationRoleSeedsSerineSpinocerebellar AtaxiasStructureTertiary Protein StructureTestingTestosteroneTherapeuticToxic effectTransgenic MiceWorkandrogen deprivation therapyandrogenicbaseefficacy testingin vivoin vivo Modelinsightmouse modelmutantneuron lossneuroprotectionnovel therapeuticspolyglutaminepreventprotein misfoldingpublic health relevancereceptorresponseselective androgen receptor modulatorspinal and bulbar muscular atrophytherapeutic target
中文摘要
项目摘要:
许多神经退行性疾病,包括阿尔茨海默病,帕金森病和
多聚谷氨酰胺疾病是由多种遗传因素引起的蛋白质错误折叠和积累引起的,
和/或环境原因。脊髓延髓肌萎缩症(SBMA)是一种成人发病,遗传性,
由雄激素受体(AR)内的多聚谷氨酰胺扩增引起的神经肌肉疾病;
它与多聚谷氨酰胺扩增引起的其他神经退行性疾病有关,包括
亨廷顿氏病和几种脊髓小脑共济失调。虽然通往
神经元功能障碍和死亡是未知的,评价转基因小鼠和细胞模型,
这些疾病已经产生了对疾病发病机理的机械见解。SBMA除了
其他多聚谷氨酰胺疾病,因为其发病和进展依赖于AR雄激素
配体。我们的SBMA细胞和小鼠模型再现了雄激素和多聚谷氨酰胺依赖的
在患者中观察到的核AR聚集,以及随之而来的毒性,使得这些模型
对于AR毒性中涉及的上游事件的机制基础的分析非常有用。我们
长期目标是使用这些模型来发展对步骤的机械理解
在SBMA发病机制中,发生在对激素结合的反应中,
基于这种理解的方法。我们之前的研究表明,
在激素结合时发生的AR的构象状态,N/C相互作用,是
其聚集和毒性;抑制N/C相互作用在体外和体内均具有保护作用
模型此外,我们发现Ser-16磷酸化是这种保护所必需的。我们提出
在本申请中,为了进一步理解AR N/C
相互作用和Ser-16磷酸化。此外,我们建议筛选选择性AR
调节剂(SARM),其阻止AR N/C相互作用以影响SBMA发病机制,
无论是在体外还是在体内。我们预计,这些研究的结果将引导我们找到一种新的
了解SBMA的分子发病机制,促进我们开发新的
治疗SBMA。
英文摘要
Project Summary:
Many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and the
polyglutamine diseases, result from protein misfolding and accumulation due to a variety of genetic
and/or environmental causes. Spinal and bulbar muscular atrophy (SBMA) is an adult-onset, inherited
neuromuscular disease that is caused by polyglutamine expansion within the androgen receptor (AR);
it is related to other neurodegenerative diseases caused by polyglutamine expansion, including
Huntington's disease and several spinocerebellar ataxias. Although the precise pathway leading to
neuronal dysfunction and death is unknown, the evaluation of transgenic mouse and cell models of
these diseases has yielded mechanistic insights to disease pathogenesis. SBMA stands apart from
other polyglutamine diseases in that its onset and progression are dependent on AR androgenic
ligands. Our cell and mouse models of SBMA reproduce the androgen- and polyglutamine-dependent
nuclear AR aggregation seen in patients, as well as its consequent toxicity, making these models
highly useful for the analysis of the mechanistic basis for upstream events involved in AR toxicity. Our
long-term objectives are to use these models to develop a mechanistic understanding of steps
in SBMA pathogenesis that occur in response to hormone binding and to develop therapeutic
approaches based on that understanding. Our previous studies revealed that a specific
conformational state of the AR that occurs upon hormone binding, the N/C interaction, is required for
its aggregation and toxicity; inhibition of the N/C interaction is protective in both in vitro and in vivo
models. Moreover, we found that Ser-16 phosphorylation is required for this protection. We propose
in this application to further understand the mechanism underlying the role of both the AR N/C
interaction and Ser-16 phosphorylation in disease. In addition, we propose to screen selective AR
modulators (SARMs) that prevent the AR N/C interaction for their effects on SBMA pathogenesis,
both in vitro and in vivo. We anticipate that results from these studies will lead us to a new
understanding of the molecular pathogenesis of SBMA and enhance our development of new
therapies for SBMA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic strategies to rescue metabolic deficiencies in spinal and bulbar muscular atrophy
-
批准号:10826086
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2023
-
负责人:DIANE E MERRY
-
依托单位:
Determining the role of AR transcriptional function in SBMA
-
批准号:9897150
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2019
-
负责人:DIANE E MERRY
-
依托单位:
Determining the role of AR transcriptional function in SBMA
-
批准号:10210450
-
项目类别:
-
资助金额:$44.02万
-
财政年份:2019
-
负责人:DIANE E MERRY
-
依托单位:
Determining the role of AR transcriptional function in SBMA
-
批准号:10022168
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2019
-
负责人:DIANE E MERRY
-
依托单位:
Determining the role of AR transcriptional function in SBMA
-
批准号:10475594
-
项目类别:
-
资助金额:$44.02万
-
财政年份:2019
-
负责人:DIANE E MERRY
-
依托单位:
Determining the role of AR transcriptional function in SBMA
-
批准号:10687111
-
项目类别:
-
资助金额:$44.02万
-
财政年份:2019
-
负责人:DIANE E MERRY
-
依托单位:
The AR N/C interaction in SBMA - Mechanistic role and therapeutic potential
-
批准号:10341213
-
项目类别:
-
资助金额:$46.62万
-
财政年份:2018
-
负责人:DIANE E MERRY
-
依托单位:
The Role of the AR Interactome in SBMA
-
批准号:10112972
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2018
-
负责人:DIANE E MERRY
-
依托单位:
The Role of the AR Interactome in SBMA
-
批准号:10341134
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2018
-
负责人:DIANE E MERRY
-
依托单位:
Nuclear mechanisms of polyglutamine toxicity in SBMA
-
批准号:9288238
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2015
-
负责人:DIANE E MERRY
-
依托单位:
Nuclear mechanisms of polyglutamine toxicity in SBMA
-
批准号:9070023
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2015
-
负责人:DIANE E MERRY
-
依托单位:
The role of androgen receptor acetylation in the polyglutamine disease SBMA
-
批准号:8286150
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2011
-
负责人:DIANE E MERRY
-
依托单位:
The Role of the AR N/C Interaction in SMBA
-
批准号:8664458
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2011
-
负责人:DIANE E MERRY
-
依托单位:
The Role of the AR N/C Interaction in SMBA
-
批准号:8227179
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2011
-
负责人:DIANE E MERRY
-
依托单位:
The role of androgen receptor acetylation in the polyglutamine disease SBMA
-
批准号:8176628
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2011
-
负责人:DIANE E MERRY
-
依托单位:
The Role of the AR N/C Interaction in SMBA
-
批准号:8853344
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2011
-
负责人:DIANE E MERRY
-
依托单位:
The Role of the AR N/C Interaction in SMBA
-
批准号:8286847
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2011
-
负责人:DIANE E MERRY
-
依托单位:
The Role of the AR N/C Interaction in SMBA
-
批准号:8473292
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2011
-
负责人:DIANE E MERRY
-
依托单位:
Inhibiting the Androgen Receptor N/C Interaction to Treat SBMA
-
批准号:8110521
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2010
-
负责人:DIANE E MERRY
-
依托单位:
Inhibiting the Androgen Receptor N/C Interaction to Treat SBMA
-
批准号:7976646
-
项目类别:
-
资助金额:$19.34万
-
财政年份:2010
-
负责人:DIANE E MERRY
-
依托单位:
海外基金